Letter: Intestinal permeability accounting for ongoing gastrointestinal symptoms following endoscopic remission in IBD-Authors' reply.
Saved in:
| Title: | Letter: Intestinal permeability accounting for ongoing gastrointestinal symptoms following endoscopic remission in IBD-Authors' reply. |
|---|---|
| Authors: | Aliu A; Department Gastroenterology and Hepatology, Maastricht University Medical Center, Maastricht, The Netherlands.; NUTRIM School of Nutrition and Translational Research in Metabolism, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands., Bosch DHCA; Department Gastroenterology and Hepatology, Maastricht University Medical Center, Maastricht, The Netherlands.; NUTRIM School of Nutrition and Translational Research in Metabolism, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands., Keszthelyi D; Department Gastroenterology and Hepatology, Maastricht University Medical Center, Maastricht, The Netherlands.; NUTRIM School of Nutrition and Translational Research in Metabolism, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands., Ardabili AR; Department Gastroenterology and Hepatology, Maastricht University Medical Center, Maastricht, The Netherlands.; NUTRIM School of Nutrition and Translational Research in Metabolism, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands., Colombel JF; Department of Medicine, The Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Sawyer R; IBD Patient Advocacy, Founder of the Bottom Line IBD and IBD Women, London, UK., Törnblom H; Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Hart A; IBD Unit, St Mark's Hospital & Imperial College, London, UK., Jonkers DMAE; Department Gastroenterology and Hepatology, Maastricht University Medical Center, Maastricht, The Netherlands.; NUTRIM School of Nutrition and Translational Research in Metabolism, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands., Pierik MJ; Department Gastroenterology and Hepatology, Maastricht University Medical Center, Maastricht, The Netherlands.; NUTRIM School of Nutrition and Translational Research in Metabolism, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands., Mujagic Z; Department Gastroenterology and Hepatology, Maastricht University Medical Center, Maastricht, The Netherlands.; NUTRIM School of Nutrition and Translational Research in Metabolism, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands. |
| Source: | Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2024 Jun; Vol. 59 (12), pp. 1646-1647. Date of Electronic Publication: 2024 May 10. |
| Publication Type: | Letter; Comment |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1365-2036 |
|---|---|
| DOI: | 10.1111/apt.18031 |
